IAI CONFERENCE: Comparing the quality of life of neuropathic patients treated with gabapentin and pregabalin at the neuropathic poly of the NTB provincial hospital in 2019

Authors

  • Nurul Qiyaam Universitas Muhammadiyah Mataram, Indonesia
  • Baiq Leny Nopitasari Universitas Muhammadiyah Mataram, Indonesia
  • Haerul Muhajiji Universitas Muhammadiyah Mataram, Indonesia

DOI:

https://doi.org/10.46542/pe.2021.212.225229

Keywords:

EQ-5D-3L, EQ-VAS, Gabapentin, Neuropathic pain, Pregabalin, Quality of life

Abstract

Introduction: Neuropathic pain is caused by the malfunctioning of the central nervous system or the peripheral nervous system. This pain is chronic and so it disrupts a patient’s quality of life which can lead to them becoming frustrated.   

Aim: The purpose of this study was to compare the quality of life of neuropathic patients using either gabapentin or pregabalin at the neuropathic clinic of the Regional General Hospital of West Nusa Tenggara Province in 2019.                   

Methods: This study used a cross-sectional study design. The sampling technique that was used was purposive sampling which was carried out by filling out the EQ-5D-3L and EQ-VAS questionnaires.   

Results: The results showed no significant difference between the quality of life of the patients using gabapentin and the patients using pregabalin as the EQ-5D-3L questionnaire had a value of p = 0.683. There was no significant difference between the quality of life between the gabapentin and pregabalin groups using the EQ-VAS questionnaire which had a value of p = 1.000.

Author Biographies

Nurul Qiyaam, Universitas Muhammadiyah Mataram, Indonesia

Department of Pharmacology and Clinical Pharmacy, Faculty of Health Sciences

Baiq Leny Nopitasari, Universitas Muhammadiyah Mataram, Indonesia

Department of Pharmacology and Clinical Pharmacy, Faculty of Health Sciences

Haerul Muhajiji, Universitas Muhammadiyah Mataram, Indonesia

Department of Pharmacy, Faculty of Health Sciences

References

Annisa, W. R. (n.d.). Penilaian kualitas hidup pada usia lanjut dengan EQ-5D di klub Jantung Sehat Kelurahan Pondok Kelapa dan faktor-faktor yang mempengaruhi = Quality of life using EQ- 5D in elderly joining klub Jantung Sehat Kelurahan Pondok Kelapa and influence factors. 2

Argoff, C. E., Backonja, M.-M., Belgrade, M. J., Bennett, G. J., Clark, M. R., Cole, B. E., Fishbain, D. A., Irving, G. A., McCarberg, B. H., & McLean, M. J. (2006). Consensus guidelines: Treatment planning and options. Diabetic peripheral neuropathic pain. Mayo Clinic Proceedings, 81(4 Suppl), S12-25. https://doi.org/10.1016/S0025-6196(11)61475-4

Backonja, M., Beydoun, A., Edwards, K. R., Schwartz, S. L., Fonseca, V., Hes, M., LaMoreaux, L., & Garofalo, E. (1998). Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA, 280(21), 1831–1836 https://doi.org/10.1001/jama.280.21.1831

Boyle, J., Eriksson, M. E. V., Gribble, L., Gouni, R., Johnsen, S., Coppini, D. V., & Kerr, D. (2012). Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: Impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care, 35(12), 2451–2458 https://doi.org/10.2337/dc12-0656

Centre for Clinical Practice at NICE (UK). (2013). Neuropathic Pain: The Pharmacological Management of Neuropathic Pain in Adults in Non-specialist Settings. National Institute for Health and Care Excellence, (UK). Available at: http://www.ncbi.nlm.nih.gov/books/NBK266257/

Davari, M., Amani, B., Amani, B., Khanijahani, A., Akbarzadeh, A., & Shabestan, R. (2020). Pregabalin and gabapentin in neuropathic pain management after spinal cord injury: A systematic review and meta-analysis. The Korean Journal of Pain, 33(1), 3–12. https://doi.org/10.3344/kjp.2020.33.1.3

G, C., Nb, F., Ts, J., J, S., M, S., P, S., Rd, T., Jm, Z., & T, N. (2016). Trigeminal neuralgia: New classification and diagnostic grading for practice and research. Neurology, 87(2), 220–228. https://doi.org/10.1212/WNL.0000000000002840

Harden, R. N. (2005). Chronic Neuropathic Pain: Mechanisms, Diagnosis, and Treatment. The Neurologist, 11(2), 111–122. https://doi.org/10.1097/01.nrl.0000155180.60057.8e

Horizant Monograph. (2012). 15

Hutapea, F. S., Kembuan, M. A. H. N., & P.s, J. M. (2016). Gambaran klinis neuropati pada pasien diabetes melitus di Poliklinik Neurologi RSUP Prof. Dr. R. D. Kandou periode Juli 2014 – Juni 2015. E-CliniC, 4(1), Article 1. https://doi.org/10.35790/ecl.4.1.2016.12115

Imdad, A., Mullany, L. C., Baqui, A. H., El Arifeen, S., Tielsch, J. M., Khatry, S. K., Shah, R., Cousens, S., Black, R. E., & Bhutta, Z. A. (2013). The effect of umbilical cord cleansing with chlorhexidine on omphalitis and neonatal mortality in community settings in developing countries: A meta-analysis. BMC Public Health, 13(Suppl 3), S15. https://doi.org/10.1186/1471-2458-13-S3-S15

Kukkar, A., Bali, A., Singh, N., & Jaggi, A. S. (2013). Implications and mechanism of action of gabapentin in neuropathic pain. Archives of Pharmacal Research, 36(3), 237–251. https://doi.org/10.1007/s12272-013-0057-y

Myr, R. K., Bere, E., & Øverby, N. C. (2015). Test-retest reliability of a new questionnaire on the diet and eating behavior of one year old children. BMC Research Notes, 8(1), 16. https://doi.org/10.1186/s13104-014-0966-y

Reynolds, G. H. (2005). Centers for Disease Control and Prevention (CDC). In Encyclopedia of Biostatistics. American Cancer Society. https://doi.org/10.1002/0470011815.b2a17021

Snedecor, S. J., Sudharshan, L., Cappelleri, J. C., Sadosky, A., Mehta, S., & Botteman, M. (2014). Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy. Pain Practice: The Official Journal of World Institute of Pain, 14(2), 167–184. https://doi.org/10.1111/papr.12054

Utami, P., Ikawati, Z., & Setyaningsih, -. (2013). Perbandingan Efek Terapi Gabapentin dan Amitriptilin pada Pasien Stroke dengan Nyeri Neuropati. Mutiara Medika: Jurnal Kedokteran dan Kesehatan, 13(2), 89–97

Downloads

Published

28-07-2021

How to Cite

Qiyaam, N. ., Nopitasari, B. L. ., & Muhajiji, H. . (2021). IAI CONFERENCE: Comparing the quality of life of neuropathic patients treated with gabapentin and pregabalin at the neuropathic poly of the NTB provincial hospital in 2019. Pharmacy Education, 21(2), p. 225–229. https://doi.org/10.46542/pe.2021.212.225229

Issue

Section

Conference Proceedings